SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10KSB/A - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]: [Amend]
SEC Accession No. 0001096906-08-000595
Filing Date
2008-04-01
Accepted
2008-04-01 15:29:45
Documents
5
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 AMEXDRUG CORPORATION FORM 10-KSB/A (AMENDMENT NO. 1) DECEMBER 31, 2007 amexdrug10ksba.txt 10KSB/A 130215
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES amexdrug10ksbaexh311.txt EX-31.1 3945
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES amexdrug10ksbaexh312.txt EX-31.2 3946
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER THIS FILING PURSUANT TO SECTION 906 OF amexdrug10ksbaexh321.txt EX-32.1 1541
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER THIS FILING PURSUANT TO SECTION 906 OF amexdrug10ksbaexh322.txt EX-32.2 1542
  Complete submission text file 0001096906-08-000595.txt   142801
Mailing Address 369 SOUTH DOHENY DR SUITE 326 BEVERLY HILLS CA 90211
Business Address 369 SOUTH DOHENY DR SUITE 326 BEVERLY HILLS CA 90211 3108550475
AMEXDRUG CORP (Filer) CIK: 0000045621 (see all company filings)

IRS No.: 952251025 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10KSB/A | Act: 34 | File No.: 001-10304 | Film No.: 08729204
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
Assistant Director 9